The Myopia Treatment Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for myopia treatment has experienced significant growth recently. The market, which was valued at $17.82 billion in 2024, is projected to reach $19.58 billion in 2025, growing at a Compound Annual Growth Rate (CAGR) of 9.9%.
The Myopia Treatment Global Market is projected to reach a value of $28.16 billion in 2029, with a compound annual growth rate (CAGR) of 9.5%.
Download Your Free Sample of the 2025 Myopia Treatment Market Report and Uncover Key Trends Now!The key drivers in the myopia treatment market are:
•Rising occurrence of distance vision impairment
•Increasing use of digital channels
•Expansion of healthcare infrastructure
•Rising incidence of myopia and increasing cases of vision loss
The myopia treatment market covered in this report is segmented –
1) By Type: Simple Myopia, High Myopia, Pathological Myopia
2) By Treatment: Eyeglasses, Contact Lenses, Refractive Surgery, Laser-Assisted In Situ Keratomileusis (LASIK), Photorefractive Keratectomy (PRK), Orthokeratology (Ortho-K)
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Direct Tender, Retail Sales, Other Distribution Channels
5) By End-User: Hospital Or Clinical Laboratories, Physician Offices, Reference Laboratories, Other End-Users
Subsegments:
1) By Simple Myopia: Mild Myopia, Moderate Myopia
2) By High Myopia: Severe Myopia, Very Severe Myopia
3) By Pathological Myopia: Degenerative Myopia, Malignant Myopia
The key trends in the myopia treatment market are:
•One emerging trend is the adoption of rigid gas-permeable contact lenses for myopia treatment.
•There is also a trend towards advancements in light-based therapies for correcting vision.
•Cutting-edge research investigating genetic factors contributing to myopia is another significant trend.
•The development and adoption of digital platforms, apps, and advanced atropine eye drops are also shaping the future of the myopia treatment market.
Major players in the myopia treatment market are:
• Regeneron Pharmaceuticals Inc.
• Alcon Inc.
• Bausch Health Companies Inc.
• Hoya Corporation
• Johnson & Johnson Vision Care Inc.
• CooperVision Inc.
• Menicon Co. Ltd.
• Topcon Healthcare Inc.
• Essilor Ltd.
• NIDEK CO. LTD.
• SightGlass Vision Inc.
• SCHWIND eye-tech-solutions GmbH
• Visioneering Technologies Inc.
• MEDMONT INTERNATIONAL PTY LTD.
• Vyluma Inc.
• Haag-Streit Holding AG
• NovaSight Ltd.
• Euclid Vision Corporation
• Treehouse Eyes LLC
• Sydnexis Inc.
• Neurobit Technologies Co. Ltd.
• Kubota Pharmaceutical Holdings Co. Ltd.
Asia Pacific was the largest region in the myopia treatment market in 2024